Table 3.
Susceptibility of Staphylococcus pathogens to antibiotics.
| Antibiotics | 2016 ( n = 5) | 2017 ( n = 6) | 2018 ( n = 7) | 2019 ( n = 6) | Total ( n = 24) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | |
| Cefazolin | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Ceftazidime | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Cefoperazone | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Cefodizime | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Gentamicin | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Ciprofloxacin | 3 | 60.0 | 2 | 33.3 | 0 | / | 0 | / | 5 | 20.8 |
| Levofloxacin | 4 | 80.0 | 4 | 66.7 | 0 | / | 3 | 50.0 | 11 | 45.8 |
| Imipenem | 4 | 80.0 | 3 | 50.0 | 3 | 42.8 | 4 | 66.7 | 14 | 58.3 |
| Tetracycline | 1 | 20.0 | 0 | / | 4 | 57.1 | 3 | 50.0 | 8 | 33.3 |
| Chloramphenicol | 3 | 60.0 | 2 | 33.3 | 0 | / | 4 | 66.7 | 9 | 37.5 |
| Piperacillin | 0 | / | 0 | / | 0 | / | 0 | 0 | / | |
| Vancomycin | 5 | 100.0 | 6 | 100.0 | 7 | 100.0 | 6 | 100.0 | 24 | 100.0 |
| Clindamycin | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Amikacin | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Meropenem | 4 | 80.0 | 5 | 83.3 | 5 | 71.4 | 4 | 66.7 | 18 | 75.0 |
| Rifampicin | 4 | 80.0 | 3 | 50.0 | 6 | 85.7 | 0 | / | 13 | 54.2 |